Cagrilintide research pharmacology: defining the question Cagrilintide is described in the scientific literature as a long-acting amylin analogue and as a dual amylin and calcitonin receptor agonist (DACRA). Its value in research discussion is not a shortcut to a clinical conclusion; it is a way to examine amylin-family receptor pharmacology, receptor selectivity, pathway engagement, and […]
